Physician profile
Howard B Minott
NPI 1780650697
$2,631.49
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $702 · 2020: $341 · 2021: $736 · 2022: $426 · 2023: $406 · 2024: $21.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $427.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $427.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $804.43 | 2019-2022 | |
| Axonics, INC. | $320.43 | 2021-2024 | Axonics |
| Abbvie INC. | $298.22 | 2019-2023 | |
| Boston Scientific Corporation | $118.27 | 2019-2022 | |
| Neotract INC. | $116.98 | 2020 | |
| Convatec INC. | $98.58 | 2021-2023 | |
| Antares Pharma, INC. | $91.07 | 2019-2022 | |
| Pfizer INC. | $85.52 | 2023 | |
| Teleflex LLC | $70.10 | 2021-2022 | |
| Urovant Sciences INC | $68.13 | 2021-2022 | |
| Clarus Therapeutics INC. | $67.52 | 2021 | |
| Myovant Sciences INC. | $67.37 | 2021-2022 | |
| C. R. Bard, INC. & Subsidiaries | $63.11 | 2019 | |
| Endo Pharmaceuticals INC. | $58.47 | 2019-2023 | Xiaflex |
| Medtronic, INC. | $37.79 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $33.33 | 2023 | |
| Hollister Incorporated | $32.14 | 2022 | |
| Rochester Medical Corporation | $31.66 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $27.66 | 2020-2021 | |
| 180 Medical, INC. | $27.56 | 2021 | |
| Allergan, INC. | $24.01 | 2020 | |
| Abc Home Medical Supply, INC. | $23.43 | 2023 | |
| Sumitomo Pharma America, INC. | $21.49 | 2023 | Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $16.65 | 2019 | |
| Coloplast Corp | $15.17 | 2022 | |
| Janssen Biotech, INC. | $12.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Minott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.